热点话题人物,欢迎提交收录!
最优雅的名人百科,欢迎向我们提交收录。
杜立
2023-03-13 12:53
  • 杜立
  • 杜立 - 助理教授-澳门大学-个人资料

近期热点

资料介绍

个人简介

Professor Li Du joined University of Macau, Faculty of Law in January 2016. His teaching and research interests include international law, health law, biotechology law and policy.Professor Du graduated from Wuhan University, China with dual Bachelor Degrees in both law and clinic medicine in 2005, and received Doctoral Degree in law from the Faculty of Law, University of Alberta, Canada in 2014. His PhD research was on the legal and ethical issues associated with genetic-technology-assisted agricultural products, and focused specifically on the labeling regulation of genetically modified organisms (GMOs). Professor Du’s research interests have also touched upon legal, ethical, and social issues related to other cutting edge biotechniques, e.g., stem cell research and clinical application, medical tourism, genetic testing and gene patents, etc. He was a Canadian Institutes for Health Research Health Law and Policy Programme fellow and sit on Trainee Communications Committee of Stem Cell Network. Before he joined the University of Macau, he worked with Health Law Institute, University of Alberta as a Research Associate and Genome Alberta (GAB) as a GE3LS coordinator.

近期论文

Book Chapters“The legal framework for genetic testing in China: achievements and challenges” in Inégalités d’accès aux soins et aux services médicaux – Recherche médicale, innovation et nouvelles technologies, Anne Marie Duguet coord. Les Études Hospitalières Éditions (LEH Group Bordeaux, 2017), pp. 211-223.Chapter 1 in GUO Yujun et al., Protection of Cultural Heritage in the Context of International Laws and Comparative laws (in Chinese), Wuhan University Press, 2011Journal ArticlesLi Du, Sijie Lin, and Kalina Kamenova. Framing Ethical Concerns and Attitudes towards Human Gene Patents in the Chinese Press, Asian Bioethics Review, 2020. doi: 10.1007/s41649-020-00136-0. (ESCI)Li Du and Meng Wang. Chinese CoViD-19 Epidemic Prevention and Control Measures: A Brief Review, BioLaw Journal, 1S 2020. (ESCI)Li Du and Meng Wang. Genetic Privacy and Data Protection: A Review of Chinese Direct-to-Consumer Test Services. Frontiers in Genetics. 11:416, 2020. doi: 10.3389/fgene.2020.00416. (SCI)Tianji Cai, Yisu Zhou, Li Du, et al. Mapping the Trafficking of Women in China: Evidence from Court Sentences. Journal of Contemporary China. Vol. 12(3), 2019. (SSCI)Li Du and Samuel Becher. Genetic and Genomic Consultation: Are We Ready for Direct-to-Consumer Telegenetics?. Frontiers in Genetics. 9:550, 2018. doi: 10.3389/fgene.2018.00550. (SCI)Li Du. A Review of Judge-Directed Negotiations in Medical Malpractice Cases. Chinese Yearbook of Private International Law and Comparative Law (《中国国际私法与比较法年刊》), Vol. 21, 2018. (CSSCI)Li Du. Patenting Human Genes: Chinese Academic Articles’ Portrayal of Gene Patents. BMC Medical Ethics, 2018. doi: 10.1186/s12910-018-0271-8. (SSCI)Tianji Cai, Li Du, et al. Characteristics of Cybercrimes: Evidence from Chinese Judgment Documents. Police Practice and Research, Vol. 19, 2018. (Web of Science)Li Du and Mingfei Ma. Privacy vs. Health Right – Should Hospitals Disclose HIV Status with Patients’ Partners? An Analysis of Perspectives on Social Networking in China. Medicine and Law, Vol. 37:1, 2018. (Web of Science)Jia Tian and Li Du (Corresponding author). Micro-blogging Violent Attacks on Medical Staff: A Case Study of the Longmen County People’s Hospital Incident. BMC Health Services Research, Vol. 17, 2017. (SCI)Li Du, Blake Murdoch, Carina Chiu and Timothy Caulfield. Compelled Disclosure of Confidential Information in Patient Safety Research. Journal of Patient Safety, Nov. 2, 2016. (SSCI)Li Du, Christen Rachul and Timothy Caulfield. Gordie Howe’s Miraculous Treatment: a Case Study of Twitter Users’ Reactions to a Sport Celebrity’s Stem Cell Treatment. Journal of Medical Internet Research Public Health and Surveillance, Vol. 2:1, 2016. (ESCI)Li Du, Kalina Kamenova and Timothy Caulfield. The Gene Patent Controversy on Twitter: A Case Study of Twitter Users’ Responses to the CHEO Lawsuit against Long QT Gene Patents. BMC Medical Ethics, Vol. 16(1):55, 2015. (SSCI)Maeghan Toews, Li Du, et al. Inter-Jurisdictional Comparison of Professional Regulations as a Tool to Address Stem Cell Tourism. Health Law Review, Vol. 22:3, 2014. (Peer-reviewed Journal)Li Du. GMO Labeling and the Consumer’s Right to Know: A Comparative Review of Legal Basis of the Consumer’s Right for Genetically Modified Food Labeling. McGill Journal of Law and Health, Vol. 8, 2014. (Web of Science)Ubaka Ogbogu, Li Du, et al. Policy Recommendations for Addressing Privacy Challenges Associated with Cell-based Research and Interventions. BMC Medical Ethics, Vol. 15:7, 2014. (SSCI)Li Du and Christen Rachul. A Brief Review on Chinese Informed Consent. Health Law Review, Vol. 21: 2, 2013. (Peer-reviewed Journal)Ubaka Ogbogu, Li Du, Christen Rachul, Lisa Belanger, Timothy Caulfield. Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and Their Providers. Stem Cell Review and Reports, Vol. 9: 2, 2013. (SCI)Li Du and Christen Rachul. Chinese Newspaper Coverage of Genetically Modified Organisms. BMC Public Health, Vol. 12:326, 2012. (SCI)Li Du and Guo Yujun. ADR for the Settlement of Medical-Malpractice Damage Dispute (in Chinese). Law Review (《法学评论》), Vol. 2, 2010. (CSSCI)

相关热点

扫码添加好友